Physician profile
Shaw S Chen
NPI 1043233281
$1,149.68
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.19 · 2020: $33.18 · 2021: $46.83 · 2022: $106 · 2023: $99.05 · 2024: $511 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $222.99 | 2023-2025 | |
| Abbvie INC. | $169.51 | 2022-2024 | Rinvoq |
| Recordati_rare_diseases_inc. | $150.32 | 2024-2025 | Isturisa, Signifor Lar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.17 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $115.21 | 2024 | Jardiance, Mounjaro |
| Novo Nordisk INC | $67.01 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $49.26 | 2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $45.92 | 2025 | Korlym |
| Amarin Pharma, INC. | $33.18 | 2020 | |
| Abbott Laboratories | $24.86 | 2023 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $24.56 | 2023 | Gvoke Hypopen |
| Mannkind Corporation | $24.46 | 2021 | |
| Covidien LP | $21.19 | 2019 | |
| Echosens North America, INC. | $19.42 | 2025 | Fibroscan |
| Insulet Corporation | $18.56 | 2024 | Omnipod |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.06 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaw Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.